Drug Profile


Alternative Names: Aflamin; Airtal; Airtal Difucrem; Barcan; Biofenac; Bristaflam; Cartrex; Falcol; Falcol Difucrem; Gerbin; Gerbin Difucrem; PR 82/3; Preservex; YT 919

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Almirall-Prodesfarma
  • Developer Almirall S.A.; ASKA Pharmaceutical; Daewoong Pharmaceutical; Farma Lepori; Gedeon Richter; Pfizer; Probios; Roche; Sanofi; Sanofi Winthrop; Sintesa; UCB; Yakult Honsha
  • Class Antirheumatics; Esters; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Ankylosing spondylitis; Osteoarthritis; Rheumatic disorders; Rheumatoid arthritis
  • Discontinued Inflammation; Pain

Most Recent Events

  • 03 Oct 2005 Grelan Pharmaceutical has merged with Teikoku Hormone to form ASKA Pharmaceutical
  • 26 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis
  • 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top